PRIMARY STUDY
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
Key Findings: These results demonstrate an effect of fatty acid amide hydrolase inhibition on the motor symptoms of Parkinson's disease in two distinct experimental models that is mediated by cannabinoid receptors.
Type of Study: Animal Study
Study Result: Positive
Study Location(s): Spain, United States
Year of Pub: 2016
Cannabinoids Studied: Fatty Acid Amide Hydrolase (FAAH), Other Related Compounds
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1, CB2
Ligands Studied: Dopamine
